上尿路尿路上皮癌后的膀胱肿瘤复发
Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract.
作者信息
Lonergan Peter E, Porten Sima P
机构信息
Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
出版信息
Transl Androl Urol. 2020 Aug;9(4):1891-1896. doi: 10.21037/tau.2020.03.47.
Abstract
Upper tract urothelial carcinoma (UTUC) is a relatively uncommon and poorly investigated malignancy, however, bladder recurrence after radical nephroureterectomy (RNU) is a frequent event. In this review, we summarize the current knowledge on risk prediction of bladder tumor recurrence after RNU, including surgical strategies and adjuvant intravesical treatments to reduce the risk of recurrence. Finally, we outline some of the more recent advances in genomics that will likely lead to new prognostic markers and risk stratification tools that may refine UTUC treatment in the future.
摘要
上尿路尿路上皮癌（UTUC）是一种相对罕见且研究较少的恶性肿瘤，然而，根治性肾输尿管切除术（RNU）后膀胱复发是常见事件。在本综述中，我们总结了目前关于RNU后膀胱肿瘤复发风险预测的知识，包括手术策略和辅助膀胱内治疗以降低复发风险。最后，我们概述了基因组学方面的一些最新进展，这些进展可能会带来新的预后标志物和风险分层工具，有望在未来优化UTUC的治疗。
相似文献
1
Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract.上尿路尿路上皮癌后的膀胱肿瘤复发
Transl Androl Urol. 2020 Aug;9(4):1891-1896. doi: 10.21037/tau.2020.03.47.
2
Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy.接受根治性肾输尿管切除术的上尿路尿路上皮癌患者术后复发和生存预测的部位特异性风险分层模型：辅助治疗的更好分层
Eur Urol Open Sci. 2022 May 30;41:95-104. doi: 10.1016/j.euros.2022.05.004. eCollection 2022 Jul.
3
Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌后膀胱内卡介苗治疗后续非肌层浸润性膀胱癌的结果。
BJU Int. 2018 May;121(5):764-773. doi: 10.1111/bju.14111. Epub 2018 Jan 21.
4
Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies.上尿路尿路上皮癌手术后的膀胱复发：危险因素与管理策略的当代综述
Eur Urol Open Sci. 2023 Jan 28;49:60-66. doi: 10.1016/j.euros.2023.01.004. eCollection 2023 Mar.
5
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.腹腔镜肾输尿管切除术与开放根治性肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局：欧洲泌尿外科学会指南系统评价。
Eur Urol Focus. 2019 Mar;5(2):205-223. doi: 10.1016/j.euf.2017.10.003. Epub 2017 Nov 15.
6
Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.根治性肾输尿管切除术后上尿路尿路上皮癌膀胱复发的风险分层
BJU Int. 2015 May;115(5):705-12. doi: 10.1111/bju.12707. Epub 2015 Jan 21.
7
Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.根治性肾输尿管切除术治疗后局限性上尿路上皮癌患者膀胱内复发的危险因素和肿瘤学结果：一项倾向评分匹配的病例对照研究。
Int J Surg. 2020 Apr;76:28-34. doi: 10.1016/j.ijsu.2020.02.015. Epub 2020 Feb 17.
8
Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience.上尿路尿路上皮癌手术治疗后膀胱内复发的危险因素及预后：一项30年单中心经验
Arab J Urol. 2017 May 9;15(3):216-222. doi: 10.1016/j.aju.2017.03.006. eCollection 2017 Sep.
9
Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路尿路上皮癌后膀胱内复发的临床意义。
Int J Urol. 2016 May;23(5):378-84. doi: 10.1111/iju.13054. Epub 2016 Jan 18.
10
Upper urinary tract disease: what we know today and unmet needs.上尿路疾病：我们如今所了解的情况及未满足的需求。
Transl Androl Urol. 2015 Jun;4(3):261-72. doi: 10.3978/j.issn.2223-4683.2015.05.01.
引用本文的文献
1
Differential Risk Factors for Early Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Carcinoma According to the History of Non-Muscle Invasive Bladder Cancer.根据非肌层浸润性膀胱癌病史，上尿路癌根治性肾输尿管切除术后早期膀胱内复发的差异危险因素
Int J Urol. 2025 May;32(5):567-574. doi: 10.1111/iju.70009. Epub 2025 Feb 13.
2
Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.内镜介入与根治性肾输尿管切除术治疗局限性上尿路上皮癌的比较：系统评价和荟萃分析。
World J Urol. 2024 May 14;42(1):318. doi: 10.1007/s00345-024-05032-y.
3
Renal function change after radical cystectomy for urothelial carcinoma patients with a solitary kidney may be independent of urinary diversion type.根治性膀胱切除术治疗孤立肾尿路上皮癌患者的肾功能变化可能与尿流改道术式无关。
Investig Clin Urol. 2023 Sep;64(5):457-465. doi: 10.4111/icu.20230065.
4
Complete Response of Rare Sarcomatoid Upper Tract Urothelial Carcinoma Variant: Case Report and Literature Review.罕见肉瘤样上尿路尿路上皮癌变异型的完全缓解：病例报告及文献综述
Case Rep Oncol. 2023 May 12;16(1):325-330. doi: 10.1159/000530264. eCollection 2023 Jan-Dec.
5
Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌手术后复发性膀胱癌的临床特征及治疗现状
Diagnostics (Basel). 2023 Mar 6;13(5):1004. doi: 10.3390/diagnostics13051004.
6
Bladder and upper urinary tract cancers as first and second primary cancers.膀胱癌和上尿路肿瘤作为首发和继发的原发性肿瘤。
Cancer Rep (Hoboken). 2021 Dec;4(6):e1406. doi: 10.1002/cnr2.1406. Epub 2021 Jun 11.
7
Prediction of survival in patients with upper tract urothelial carcinoma.上尿路尿路上皮癌患者生存情况的预测
Transl Androl Urol. 2021 Jan;10(1):536-537. doi: 10.21037/tau-20-1331.
本文引用的文献
1
Cancer statistics, 2020.癌症统计数据，2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
2
Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma.上尿路尿路上皮癌肾输尿管切除术后的单剂量膀胱内化疗。
Cochrane Database Syst Rev. 2019 May 18;5(5):CD013160. doi: 10.1002/14651858.CD013160.pub2.
3
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.上尿路和膀胱尿路上皮癌之间的克隆相关性和突变差异。
Clin Cancer Res. 2019 Feb 1;25(3):967-976. doi: 10.1158/1078-0432.CCR-18-2039. Epub 2018 Oct 23.
4
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.腹腔镜肾输尿管切除术与开放根治性肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局：欧洲泌尿外科学会指南系统评价。
Eur Urol Focus. 2019 Mar;5(2):205-223. doi: 10.1016/j.euf.2017.10.003. Epub 2017 Nov 15.
5
Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.早期输尿管结扎对预防上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的疗效：一项前瞻性单臂多中心临床试验。
Jpn J Clin Oncol. 2017 Sep 1;47(9):870-875. doi: 10.1093/jjco/hyx085.
6
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南：2017 年更新版。
Eur Urol. 2018 Jan;73(1):111-122. doi: 10.1016/j.eururo.2017.07.036. Epub 2017 Sep 1.
7
The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌膀胱内复发的条件生存时间。
J Urol. 2017 Dec;198(6):1278-1285. doi: 10.1016/j.juro.2017.06.073. Epub 2017 Jun 17.
8
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).上尿路尿路上皮癌（UTUC）的流行病学、诊断、术前评估及预后评估
World J Urol. 2017 Mar;35(3):379-387. doi: 10.1007/s00345-016-1928-x. Epub 2016 Sep 7.
9
Genomics in upper tract urothelial carcinoma.上尿路尿路上皮癌的基因组学
Curr Opin Urol. 2017 Jan;27(1):35-40. doi: 10.1097/MOU.0000000000000341.
10
Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study.上尿路尿路上皮癌与膀胱尿路上皮癌是不同的实体吗？根治性手术后尿路上皮癌的行为与解剖位置的关系：一项病例对照研究。
BMC Cancer. 2015 Mar 18;15:149. doi: 10.1186/s12885-015-1161-9.
Zotero 插件